Adjunctive glucocorticoid therapy in patients with septic shock.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS: We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS: From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS: Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationA Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Cited by
Items 801–900 of 1,000
Jarczak, D., & Nierhaus, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-17148-3_23
Over-EXTENDing the Window for Thrombolytic Therapy in Cerebrovascular Accident
Spiegel, R. J., Donnelly, J. P., & Radecki, R. P. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.07.010
Higher versus lower blood pressure targets in adults with shock
Korang, S. K., Safi, S., Feinberg, J. B., Gluud, C. N., Perner, A., & Jakobsen, J. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013470
“[PUBMED: 15973520] Venkatesh 2018 Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock.”
BackgroundSelf-citationHow does critical illness alter metabolism?
Nunnally, M., & Piper, G. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00072-9
What is the current role for corticosteroids in critical care?
Lyons, C., & Kevin, L. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00082-1
Current sepsis research: What nurses need to know
Seckel, M. A. (2020) · Nursing Critical Care · doi:10.1097/01.ccn.0000654796.79252.dc
Marino, L. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-10032020-124048
Letter to the Editor: “Our Response to Covid-19 as Endocrinologists and Diabetologists”
Snyder, S. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa325
Corticosteroids in the Treatment of Sepsis
Allen, R. W., & Tepler, P. (2020) · Academic Emergency Medicine · doi:10.1111/acem.14057
Mittal, A., & Soneja, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-4039-4_2
Vitamin C, Thiamine and Steroids: Ménage à Trois or Medical Masala
Fonseca, A. J. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23538
Does hydrocortisone reduce mortality in mechanically ventilated patients with septic shock?
Lohsandt, D., & Frazer, K. (2020) · Evidence-Based Practice · doi:10.1097/ebp.0000000000001040
Has evidence-based medicine changed the practice of critical care?
Levinson, A., & Levy, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00010-9
Important publications in intensive care in 2018/2019
Šrámek, V., Čundrle, I., Suk, P., Helán, M., & Hruda, J. (2020) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2019.074
A Review of Cytokine Storm in COVID-19
Meenakshi, L. N. U., Samadhiya, A., & Goyal, R. (2020) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0151
The vitamin C, thiamine and steroids (VICTAS) in sepsis
Akkaya, P. N. (2020) · Demiroglu Science University Florence Nightingale Transplantation Journal · doi:10.5606/dsufnjt.2020.011
“[18-22] While CORTICUS and ADRENAL studies did not show a mortality benefit, both showed that septic shock was reversed more rapidly with hydrocortisone use.[19,21] The APROCCHSS study is the first large clinical trial to show a mortality benefit to steroid therapy, probably as it used fludrocortisone therapy in combi…”
BackgroundMethodResultInfluentialRaman, S., & Peters, M. J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198794592.003.0001
Shiba, H., Minami, S., & Shiraishi, A. (2021) · CHEST Journal · doi:10.1016/j.chest.2020.08.2100
Sepsis – hämodynamische Instabilität
Reitgruber, D., & Auer, J. (2021) · Springer eBooks · doi:10.1007/978-3-662-61823-3_35
Ebrahimnegad, H., Boojar, M. M. A., Cheraghali, A. M., Shankayi, Z., Mohammadzadeh, T., Mirasheh, M. H., Poorhaji, M. M., Eidnezhad, M., Shahriari, M., Asadi, M., et al. (2021) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2021.174134
Approaches Towards the Detection of Sepsis: A Review
Heeroma, A. J., Toffrey, J., & Gwenin, C. D. (2021) · International Journal of Biomedical and Clinical Analysis · doi:10.61797/ijbca.v1i1.53
Shao, Y., Zhang, W., Zhao, T., Lu, F., Hong, Y., Liu, L., Cai, Y., Wei, N., Cheng, H., Chen, F., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-73158/v2
Marjanović, V., Budić, I., Ignjatijević, S., Stevic, M. M., & Simić, D. (2020) · Timocki medicinski glasnik · doi:10.5937/tmg2004153m
Vélez, J. W., Páez, P. A. V., Moscoso, S. X. A., Arauz, R. M. N., Tercero-Martínez, W., Rondón, É. F. L., & Vélez-Páez, J. L. (2019) · Ciencia Ecuador
Yamamoto, R., Nahara, I., Toyosaki, M., Fukuda, T., Masuda, Y., & Fujishima, S. (2020) · doi:10.21203/rs.2.24068/v1
“Low-risk-of-bias (RoB) RCTs recruited only patients with septic shock and investigated mortalities as their primary outcomes; however, their definition of refractory shock differed in the doses of vasopressors required [15, 19, 26, 27, 33].”
BackgroundLiang, H., Song, H., Song, G., Li, H., Ding, X., Kan, Q., & Sun, T. (2021) · Research Square · doi:10.21203/rs.3.rs-508536/v1
Vitamin C – neue Therapiemöglichkeit bei Sepsis?
Müller, S., Wiesmann, T., Wulf, H., & Arndt, C. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1109-4363
“Die Autoren dieser Arbeit sehen andererseits in ihren Ergebnissen Hinweise auf mögliche Vorteile einer i. v., hochdosierten Monotherapie mit Vitamin C.”
BackgroundKayaaltı, S., & Kayaaltı, Ö. (2021) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-021-00132-y
Diagnosing Sepsis in the Intensive Care Unit: A Retrospective Cohort StudyPreprint
Denny, K. J., Lindell-Innes, R., Heffernan, A. J., Paterson, D. L., McNamara, J. F., & Lipman, J. (2020) · doi:10.21203/rs.2.24071/v1
“The in-hospital and ICU mortality observed in the present study was surprisingly low, less than predicted by the APACHE II and SOFA scores for the cohort and less than that of larger international sepsis trials with comparable illness severity scores to the present cohort [17, 19, 21].”
BackgroundResultWu, Y., Lin, C.-K., Hamaya, R., Huang, F.-Y., Chien, Y.-S., Hsu, Y., Chen, S., & Papatheodorou, S. (2021) · medRxiv · doi:10.1101/2021.10.17.21265100
“Annane 2018(2) 1241 (34) Baseline SOFA score: 12 (3) HC 50mg/6h + oral FC 50mcg/d for 7 days Placebo 90-day mortality Doluee 2018(47) 160 (1) Not respond to vasopressors HC 50mg/6h for 7 days Placebo 28-day all-cause mortality Venkatesh 2018(3) 3800 (69) All patients received vasopressors HC 200mg/d, maximum of 7 days…”
BackgroundMethodInfluentialChandrasekharan, S., Mistry, R., & Frei, D. R. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198853053.003.0038
Endocrinology in the Critically Ill
den Berghe, G. V., & Langouche, L. (2022) · doi:10.1093/med/9780198870197.003.0204
Cihoric, M., Kehlet, H., Lauritsen, M. L., Højlund, J., Kanstrup, K., & Foss, N. B. (2022) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14040
Jha, V. K., & Mahapatra, D. K. (2022) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_30_21
Rauf-ul-Hassan, M., Aslam, S., Waseem, M., Bashir, I., Naz, S., & Iqbal, A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22162315
Metabolic Illness and Endocrinopathies
Young, A. J., & Duane, T. M. (2022) · Wiley eBooks · doi:10.1002/9781119756781.ch15
Shime, N. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.2252
Shao, Y., Zhang, W., Zhao, T., Lu, F., Hong, Y., Liu, L., Cai, Y., Wei, N., Cheng, H., Chen, F., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-73158/v1
“Despite advancements in treatment strategies, there is currently no approved speci c and effective treatment for this disorder [3].”
BackgroundAdrenal Emergencies in Critically Ill Cancer Patients
Richard, R. P., Grishaw, J. A., & Enfield, K. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_81
Gale, S. E. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.shock_overview
PESQUISA-AÇÃO: A IMPORTÂNCIA DE AÇÕES EDUCATIVAS SOBRE O CUIDADO COM O RECÉM-NASCIDO
Raposo, H. L. O., Silva, R. R. V., Costa, S. M. S., Silva, C. P. O., dos Santos, E. R. S., da Silva, A. N., Batista, A. K. R., & do Lago, L. B. (2020) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0000218
Venkatesh, B., & Cohen, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004014
Self-citationManagement of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_60 · Cited by 1
When Should Perioperative Glucocorticoid Replacement Be Administered?
Kozarek, K., & Head, D. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77846-6.00026-4
Key Advances in Intensive Care and the Coronavirus Disease-19 Research and Practice Boost
Mentzelopoulos, S. D., & Adamos, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123370
69/m mit rezidivierender Sigmadivertikulis, Tachypnoe und Vigilanzminderung
Mück, A., & Herter, T. (2022) · Die Anaesthesiologie · doi:10.1007/s00101-022-01146-3
Blood Cortisol as a Biomarker in Intensive Care Unit
Pektezel, M. Y., & Pektezel, L. D. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_66-1
Kobayashi, S., Yamaguchi, R., Furuta, M., Watanabe, S., Keiji, A. I. Z. U., Sato, F., Fujieda, H., Toyoda, Y., Iwata, T., Kageyama, Y., et al. (2022) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.2020.0107
ОСОБЛИВОСТІ НАЙГОСТРІШОГО СЕПСИСУ ТА СЕПТИЧНОГО ШОКУ
Kopcha, V. S., Шпікула, Н. Г., & Kadubets, S. V. (2022) · Інфекційні хвороби · doi:10.11603/1681-2727.2022.1.13024
Utilidad de los corticoides en el choque séptico
Vargas, J., & Montalvo, M. (2022) · Revista Ecuatoriana de Ciencia Tecnología e Innovación en Salud Pública · doi:10.31790/inspilip.v6iespecial.323
Et, T., Korkusuz, M., & Yarımoğlu, R. (2022) · Journal of Critical and Intensive Care · doi:10.37678/dcybd.2022.3021
Outcome of Septic Shock Patients treated with Vitamin C and Thiamine: A Prospective Cohort Study
Mallappa, M., Reddy, S. S., & Kunwar, S. (2022) · Journal of Acute Care · doi:10.5005/jp-journals-10089-0031
De patiënt met koorts en algehele malaise
de Groot, B., Verdonschot, R. J. C. G., Linzel, D. S., Bouma, H. R., van Beers, E. J., & Kaasjager, K. A. H. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2805-5_30
Inflammatory protection and management during extracorporeal membrane oxygenation
Worku, E. T., Ki, K. K., & Shekar, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18918-0.00064-4
Infections in the immunocompromised host and immunization
Bindayna, K. M., & Alsalman, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95092-3.00003-2
Heming, N., & Annane, D. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-17572-5_16
Blood Cortisol as a Biomarker in Intensive Care Unit
Pektezel, M. Y., & Pektezel, L. D. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_66 · Cited by 1
Corticosteroids in Sepsis: The Enduring Debate
Chacko, J., Pawar, S., Seppelt, I., & Brar, G. (2023) · Springer eBooks · doi:10.1007/978-981-19-9940-6_15
Mejia-Vilet, J. M., Toro-Cisneros, N. D., Caballero-Islas, A. E., Martinez-Rueda, A. J., Hernández-Flores, J., Proaño-Zamudio, J. A., Sacoto-Romo, V. M., Fernández-Camargo, D. A., Comunidad-Bonilla, R. A., Navarro-Gerrard, M. A., et al. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000034
Research Progress of Drug Treatment of Severe Pneumonia
常, 朝. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361291
Bloos, F. (2023) · Intensivmedizin up2date · doi:10.1055/a-2068-7305
Critical illness-related corticosteroid insufficiency
Burkitt, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-76469-8.00090-3
Resuscitation and Preparation of the Emergency General Surgery Patient
Waibel, B. H., & Kamien, A. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.05.011
Corticosteroids in Emergency Pathologies
Radenković, M., & Milićević, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112317
Management of endocrine disorders in the surgical intensive care unit
Nunn, A. M., & Lee, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-69787-3.00121-0 · Cited by 1
Wiel, É., Vromant, A., & Fakih, R. (2023) · EMC - Urgenze · doi:10.1016/s1286-9341(23)47926-4
Die aktuelle Sepsisleitlinie – was müssen Sie wissen?
Kochanek, M., & David, S. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01585-z
Vaught, A. “. J. (2023) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-023-00370-x
“• In APROCCHSS, vasopressor dosage needed to reach 0.25 mcg/kg/min or greater than 1 mg/h of norepinephrine or epinephrine for at least 6 h to maintain MAP > 65 mmHg [16].”
InfluentialNAEEM, O., ULLAH, A., Batool, S., SAGAR, R., NAEEM, O., & ISLAM, H. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.553
Reimagining Patient-Centered Outcome Measurement
Teixeira, C. (2023) · CHEST Critical Care · doi:10.1016/j.chstcc.2023.100032
Marino, L. O., Gómez, L. M. G., Barbeiro, D. F., Barbeiro, H. V., Brandao, R. A., Menezes, M. C. S., Bachegda, T. A. S. S., & de Sousa, H. P. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4667597
Journal of Shock and Hemodynamics, Vol. I, Iss. 2 (print version)
(2023) · Journal of shock & hemodynamics · doi:10.58464/2836-0605.1039
Zhong, J. J., Zhang, J., Lin, Y. Y., Ju, D., Mo, J., & Ye, X.-Z. (2024) · Preprints.org · doi:10.20944/preprints202402.0264.v1
Montero, V. R., Ribes, C. M., Montell, M. P., & Zaragoza, R. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.03.008
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.02.025
Kochanek, M., & David, S. (2024) · Wiener klinisches Magazin · doi:10.1007/s00740-024-00527-1
N-ACETILCISTEÍNA E HIDROCORTISONA NO MANEJO DA SEPSE: UMA REVISÃO INTEGRATIVA
Gomes, L., Bortoleto, M. M., Lopes, L. B. V., & da Rocha, B. A. (2023) · Revista Omnia Saúde · doi:10.29327/2272174.6.1-26
Tamura, T., & Sasaki, J. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.857
Colorectal Surgery in Critically Unwell Patients
Subramaniam, A., Wengritzky, R., & Bolshinsky, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-56270-9_41
Tandon, M. S., Sharma, A., Mittal, R., & Bhandari, N. (2024) · Springer eBooks · doi:10.1007/978-981-99-8059-8_24
Management of the circulation on the intensive care unit
Speed, H., & Hardy, G. (2024) · Surgery (Oxford) · doi:10.1016/j.mpsur.2024.07.002 · Cited by 1
Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be
Todi, S. K. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24798
Keith, P. D., Conrad, T. S., Eaton, J., & Scott, L. K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006157
Acute Respiratory Distress Syndrome: Updates for Critical Care Transport
Roginski, M. A., Atchinson, P. R., Esteves, A. M., Lentz, S. A., Fjeld, K. J., Markwood, J. M., Lauria, M., & Bernardoni, B. (2024) · Air Medical Journal · doi:10.1016/j.amj.2024.09.005
CORTICOSTEROIDES NO CHOQUE SÉPTICO: REVISÃO SOBRE MODULAÇÃO HEMODINÂMICA, INFLAMATÓRIA E MORTALIDADE
Lopes, L. F., de Oliveira, F. D. P. C., Lunardi, M. E., & da Silva, M. P. R. (2024) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-6036-670-1/849-856
Pomponio, R., Peterson, R., Owusu, M., Slaughter, S., Melgar, S., Jolley, S. E., & Burnham, E. L. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15495
Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series
Nguyễn, A. T., Bouajram, R. H., Brzeziński, M., Hassanipour, S., Gordon, D., Trinh, B., Deuse, T., Venado, A. E., Hays, S. R., Singer, J. P., et al. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100189
Rudakov, Y. V., Салухов, В. В., Анатольевич, Х. М., Игоревич, В. Н., & Avdeev, S. N. (2024) · PULMONOLOGIYA · doi:10.18093/0869-0189-2024-34-6-775-787
Shrestha, G. S., & Paneru, H. R. (2025) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24902
“7,8 At the time we commenced this study, there was growing evidence that addition of vitamin c and thiamine to hydrocortisone resulted in significant mortality benefit in patients with septic shock.”
1565: SHOCKINGLY VAGUE: COMPARING ADJUNCTIVE MEASURES IN SEPTIC SHOCK
Wang, H. F., Cheriyan, B., Huebner, M., Wang, S., & Sudekum, D. (2025) · Critical Care Medicine · doi:10.1097/01.ccm.0001104924.19139.7c
Otsuka, I., Nishimoto, K., Kozako, T., Kanemaru, K., Yamashita, Y., Kamoto, T., & Sawada, A. (2025) · BJUI Compass · doi:10.1002/bco2.498
“4,16 As urological septic shock constitutes a relatively small subset in these studies, its unique characteristics and management strategies remain underexplored.”
Vélez-Páez, J. L., Torres-Carpio, D. A., & Avellanas-Chavala, M. L. (2025) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2025.01.007
Jaiswal, S., Singh, R., Giri, R., Gautam, S. K., & Singh, M. (2025) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20250371
Endothelial Control of the Inflammatory Process
Adam, A. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-55254-0_9-1
Leslie, R., Johnson, E., Thomas, G., & Harrington, P. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009267441.023
Corticosteroids—A Not-So-Novel Treatment for Sepsis-Associated AKI
Sanghavi, S. F. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.12286
A double-edged sword: a narrative review on steroids in sepsis and septic shock
Guarino, M., Luppi, F., Perna, B., Maritati, M., Contini, C., Spampinato, M. D., & GIORGIO, R. D. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04008-z
“In 2018, the ADRENAL trial (Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock) provided more evidence on the use of corticosteroids in septic shock [21].”
InfluentialSepsis et choc septique de l’adulte
de Roquetaillade, C., Bousta, A., Muchardt, J., & Chousterman, B. G. (2025) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(25)47121-7
Bauer, P. R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197628638.003.0060
Metadata
- Authors
- Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., & Myburgh, J.
- Affiliations
- The University of Sydney (AU)
- From the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hospital (S.F.), Sydney, the Princess Alexandra Hospital (B.V., C.J.) and Royal Brisbane and Women’s Hospital (J.C.), University of Queensland, and the Wesley Hospital (B.V., J.C.), Brisbane, Austin Hospital (R.B.), the...
- University of Copenhagen (DK)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 797-808
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2784412824
- Cited by
- 1,037
- References
- 40
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 90 · 2023: 106 · 2022: 110 · 2021: 121 · 2020: 149 · 2019: 135 · 2018: 91
- FWCI
- 96.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Repository (Kingston University London) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- National Health and Medical Research Council (1004108, 1124926)
- Health Research Council of New Zealand (12/206)
- National Institute of Health Research, United Kingdom
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, mortality, mechanical ventilation, shock resolution, blood transfusion, intensive care unit, sepsis treatment, subgroup analysis, mechanical ventilation duration, vasopressor requirement, glycemic control
- MeSH terms
- Aged, Anti-Inflammatory Agents, Double-Blind Method, Female, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Rate, Fungemia, Bacteremia, Treatment Outcome, Chemotherapy, Adjuvant, Renal Replacement Therapy, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.